Document Detail


Management of gastric varices.
MedLine Citation:
PMID:  21199520     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although the incidence of bleeding from gastric varices is relatively low (10%-36%), the bleeding is massive once it has occurred and it increases the patient's mortality. The management of esophageal variceal bleeding is highly differentiated with several effective treatments available. In contrast, bleeding from gastric varices continues to be a therapeutic challenge. In the last decade, there have been increasing reports regarding the management of gastric varices. In this article we review recent progress in the management of gastric varices and discuss further expected studies.
Authors:
Makoto Hashizume; Tomohiko Akahoshi; Morimasa Tomikawa
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of gastroenterology and hepatology     Volume:  26 Suppl 1     ISSN:  1440-1746     ISO Abbreviation:  J. Gastroenterol. Hepatol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-04     Completed Date:  2011-04-18     Revised Date:  2012-01-30    
Medline Journal Info:
Nlm Unique ID:  8607909     Medline TA:  J Gastroenterol Hepatol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  102-8     Citation Subset:  IM    
Copyright Information:
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Affiliation:
Department of Advanced Medical Initiatives, Kyushu University, Fukuoka, Japan. mhashi@dem.med.kyushu-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Esophageal and Gastric Varices / complications,  physiopathology,  therapy*
Gastrointestinal Hemorrhage / etiology,  physiopathology,  therapy*
Hemodynamics
Hemostasis, Endoscopic
Hemostatic Techniques* / adverse effects
Hemostatics / therapeutic use
Humans
Ligation
Patient Selection
Portasystemic Shunt, Transjugular Intrahepatic
Risk Assessment
Splenectomy
Treatment Outcome
Chemical
Reg. No./Substance:
0/Hemostatics
Comments/Corrections
Comment In:
J Gastroenterol Hepatol. 2012 Jan;27(1):3-4   [PMID:  22188023 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Next Document:  Terlipressin in hepatorenal syndrome: Evidence for present indications.